MIR605
gene geneOn this page
Also known as hsa-mir-605
Summary
MIR605 (microRNA 605, HGNC:32861) is a microRNA gene on chromosome 10q21.1.
microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop.
Source: NCBI Gene 693190 — RefSeq curated summary.
At a glance
- Gene type: non-coding (miRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32861 |
| Approved symbol | MIR605 |
| Name | microRNA 605 |
| Location | 10q21.1 |
| Locus type | RNA, micro |
| Status | Approved |
| Aliases | hsa-mir-605 |
| Ensembl gene | ENSG00000207813 |
| Ensembl biotype | miRNA |
| Entrez | 693190 |
| RNAcentral | URS000075ABF4 — miRNA, 83 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 miRNA
ENST00000385078
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000385078 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001500084 | 51299573 | 51299655 |
Expression profiles
Bgee: expression breadth broad, 55 present calls, max score 88.14.
Top tissues by expression
55 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| stomach | UBERON:0000945 | 88.14 | gold quality |
| kidney | UBERON:0002113 | 85.20 | gold quality |
| adrenal tissue | UBERON:0018303 | 84.61 | gold quality |
| liver | UBERON:0002107 | 80.55 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 79.61 | gold quality |
| lung | UBERON:0002048 | 77.69 | gold quality |
| nucleus accumbens | UBERON:0001882 | 77.07 | gold quality |
| intestine | UBERON:0000160 | 76.23 | gold quality |
| endometrium | UBERON:0001295 | 74.79 | gold quality |
| heart | UBERON:0000948 | 73.41 | gold quality |
| gastrocnemius | UBERON:0001388 | 73.27 | gold quality |
| colon | UBERON:0001155 | 71.49 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 71.24 | gold quality |
| blood | UBERON:0000178 | 70.65 | gold quality |
| heart left ventricle | UBERON:0002084 | 69.73 | gold quality |
| left adrenal gland | UBERON:0001234 | 69.53 | gold quality |
| esophagus mucosa | UBERON:0002469 | 68.24 | gold quality |
| vagina | UBERON:0000996 | 68.13 | gold quality |
| transverse colon | UBERON:0001157 | 67.90 | gold quality |
| right atrium auricular region | UBERON:0006631 | 67.88 | gold quality |
| body of uterus | UBERON:0009853 | 67.72 | gold quality |
| tibial artery | UBERON:0007610 | 67.18 | gold quality |
| popliteal artery | UBERON:0002250 | 67.17 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 67.16 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 66.35 | gold quality |
| right adrenal gland | UBERON:0001233 | 66.24 | gold quality |
| ascending aorta | UBERON:0001496 | 66.11 | gold quality |
| left coronary artery | UBERON:0001626 | 65.60 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 65.56 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 65.55 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.49 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 22)
- MicroRNA miR-605 is transcriptionally activated by p53 interaction with its promotor region, and post-transcriptionally represses Mdm2. (PMID:21217645)
- There was no significant association of SNPs of miR-149 and miR-605 with lung cancer. (PMID:21671485)
- miR-605 AG/GG genotype carriers had increased susceptibilities to colorectal cancer and gastric cancer in smokers (PMID:21976437)
- Single-nucleotide polymorphism in MIRN605 is associated with biochemical recurrence in prostate cancer. (PMID:24740842)
- MiR-605 directly targets and represses PSMD10 expression. (PMID:25131931)
- Data indicate that the microRNA miR-605 SNP (rs2043556) modifies the age of cancer onset in Li-Fraumeni syndrome (LFS) patients. (PMID:25683625)
- MIR605 polymorphisms are associated with the risk of head and neck squamous cell carcinoma. (PMID:27515039)
- Low miR605 expression is associated with melanoma. (PMID:28656250)
- EN2 is negatively regulated by miR-605, and down-regulation of miR-605 promotes the proliferation and invasion of prostate cancer (PCa) cells by up-regulating EN2, which leads to PCa development and progression (PMID:28943214)
- Circular RNA circ-VANGL1 is a competing endogenous RNA which contributes to bladder cancer progression by regulating miR-605-3p/VANGL1 pathway. (PMID:30146736)
- the findings of this meta-analysis did not support an association between miR-605 rs2043556 polymorphism and cancer susceptibility. (PMID:30514199)
- Current meta-analysis indicate that the miR-605 rs2043556 may decrease susceptibility in Asian populations, especially allelic-G may be a protective factor for cancer in carriers [Meta-analysis]. (PMID:30549993)
- this study highlights the important roles of BLACAT1/miR-605-3p/VASP axis in glioma progression. (PMID:31093978)
- miR-605-5p promotes invasion and proliferation by targeting TNFAIP3 in non-small-cell lung cancer. (PMID:31452243)
- Significant Association of miR-605 rs2043556 with Susceptibility to Breast Cancer. (PMID:31556863)
- microRNA-605 rs2043556 polymorphisms affect clopidogrel therapy through modulation of CYP2B6 and P2RY12 in acute coronary syndrome patients. (PMID:31766967)
- MIR605 rs2043556 is associated with the occurrence of multiple primary tumors in TP53 p.(Arg337His) mutation carriers. (PMID:31778928)
- SNHG16/miR-605-3p/TRAF6/NF-kappaB feedback loop regulates hepatocellular carcinoma metastasis. (PMID:32436333)
- CircDDX17 acts as a competing endogenous RNA for miR-605 in breast cancer progression. (PMID:32633371)
- Hsa-miR-605 regulates the proinflammatory chemokine CXCL5 in complex regional pain syndrome. (PMID:34062414)
- Long Noncoding RNA LINC01703 Exacerbates the Malignant Properties of Non-Small Cell Lung Cancer by Upregulating MACC1 in a MicroRNA-605-3p-Mediated Manner. (PMID:34493358)
- MicroRNA-605-3p Inhibited the Growth and Chemoresistance of Osteosarcoma Cells via Negatively Modulating RAF1. (PMID:39076089)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): selective IgA deficiency disease